VALBIOTIS presents its next financial communication milestones for 2018.
Half-year report of the liquidity contract with PORTZAMPARC, with increased liquidityJanuary 31st 2018
VALBIOTIS presents the half-year report of the Liquidity contract with PORTZAMPARC and announces that its means are increased (in French).
VALBIOTIS announces a significant effect of VALEDIA® on intestinal microbiotaJanuary 22nd 2018
VALBIOTIS announces a significant effect of VALEDIA® on the microbiota imbalances associated with metabolic diseases (preclinical)
VALBIOTIS invited to participate in annual J.P. Morgan Healthcare conferenceJanuary 8th 2018
VALBIOTIS announces its participation in the 36th annual J.P. Morgan Healthcare conference, held in San Francisco from January 8th to 11th, as well as its participation in the Biotech Showcase